Annual Cash & Cash Equivalents
$71.62M$4.17M+6.19%
Summary
- Current Value
- As of today, XERS annual cash & cash equivalents is $71.62M, up +6.19% on
- Historical Performance
- XERS annual cash & cash equivalents is up +6.47% over the past 3 years, and up +266.93% over the past 5 years
- All-Time High Comparison
- XERS annual cash & cash equivalents is currently -41.28% below its historical high of $121.97M set on
- 3-Year Low Comparison
- XERS annual cash & cash equivalents is +6.19% above its 3-year low of $67.45M reached on
- Sector Comparison
- XERS annual cash & cash equivalents is higher than 58.76% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $71.62M | +6.2% | +6.5% | +266.9% | +122.0% | |
| Quarterly Cash & Cash Equivalents | $91.60M | +32.0% | -2.0% | -35.4% | – | |
| Price | $7.21 | +115.2% | +586.7% | +24.3% | – | |
| Annual Current Assets | $167.66M | +7.3% | +17.6% | +91.7% | +405.4% | |
| Annual Total Liabilities | $358.77M | +3.2% | +71.3% | – | +10000.0% | |
| Annual Working Capital | $67.22M | +10.1% | +5.8% | +11.8% | +119.3% | |
| Annual Net Income | -$54.84M | +11.9% | +55.3% | +56.3% | -315.1% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $121.97M | N/A | -41.3% |
| 5Y | $121.97M | -41.3% | |
| All | $121.97M | -41.3% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $67.45M | +6.2% | |
| 5Y | $37.60M | N/A | +90.5% |
| All | $19.52M | +266.9% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $71.62M | +6.2% | |
| $67.45M | -44.7% | |
| $121.97M | +81.3% | |
| $67.27M | +78.9% | |
| $37.60M | +92.6% |
| Year | Value | Change |
|---|---|---|
| $19.52M | -57.3% | |
| $45.72M | +8.7% | |
| $42.05M | +30.3% | |
| $32.27M | - |
FAQ
What is the current annual cash & cash equivalents of XERS?
As of today, XERS annual cash & cash equivalents is $71.62M
What is 1-year change in XERS annual cash & cash equivalents?
XERS annual cash & cash equivalents is up +6.19% year-over-year
What is 3-year change in XERS annual cash & cash equivalents?
XERS annual cash & cash equivalents is up +6.47% over the past 3 years
How far is XERS annual cash & cash equivalents from its all-time high?
XERS annual cash & cash equivalents is currently -41.28% below its historical high of $121.97M set on December 31, 2022
How does XERS annual cash & cash equivalents rank versus sector peers?
XERS annual cash & cash equivalents is higher than 58.76% of companies in Healthcare sector
When is XERS next annual earnings release?
The next annual earnings release for XERS is on
Quarterly Cash & Cash Equivalents
$91.60M$32.31M+54.50%
Summary
- Current Value
- As of today, XERS quarterly cash & cash equivalents is $91.60M, up +54.50% on
- Historical Performance
- XERS quarterly cash & cash equivalents is up +31.98% year-over-year, and down -1.96% over the past 3 years
- All-Time High Comparison
- XERS quarterly cash & cash equivalents is currently -36.39% below its historical high of $144.00M set on
- 3-Year Low Comparison
- XERS quarterly cash & cash equivalents is +56.74% above its 3-year low of $58.44M reached on
- Sector Comparison
- XERS quarterly cash & cash equivalents is higher than 55.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $91.60M | +54.5% | +32.0% | -2.0% | -35.4% | |
| Annual Cash & Cash Equivalents | $71.62M | – | +6.2% | +6.5% | +266.9% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| Quarterly Current Assets | $224.02M | +20.7% | +37.6% | +50.4% | +37.2% | |
| Quarterly Total Liabilities | $371.05M | +4.8% | +6.2% | +49.6% | +137.8% | |
| Quarterly Working Capital | $107.82M | +19.3% | +50.2% | +34.2% | -20.8% | |
| Quarterly Net Income | $621.00K | +132.2% | +104.0% | +102.8% | +103.9% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $91.60M | at high | |
| 3Y | $121.97M | N/A | -24.9% |
| 5Y | $135.89M | -32.6% | |
| All | $144.00M | -36.4% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $58.44M | +56.7% | |
| 3Y | $58.44M | +56.7% | |
| 5Y | $58.44M | +56.7% | |
| All | $42.05M | +117.9% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of XERS?
As of today, XERS quarterly cash & cash equivalents is $91.60M
What is XERS quarterly cash & cash equivalents most recent change?
XERS quarterly cash & cash equivalents was up +54.50% on September 30, 2025
What is 1-year change in XERS quarterly cash & cash equivalents?
XERS quarterly cash & cash equivalents is up +31.98% year-over-year
How far is XERS quarterly cash & cash equivalents from its all-time high?
XERS quarterly cash & cash equivalents is currently -36.39% below its historical high of $144.00M set on June 30, 2020
How does XERS quarterly cash & cash equivalents rank versus sector peers?
XERS quarterly cash & cash equivalents is higher than 55.24% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- XERS Official Website www.xerispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
- XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
- XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers